G{beta}{gamma} Recruits Rho1 to the Site of Polarized Growth during Mating in Budding Yeast*

Eli E. Bar, Alexis T. Ellicott and David E. Stone {ddagger}

From the Department of Biological Sciences, Laboratory for Molecular Biology, University of Illinois at Chicago, Chicago, Illinois 60607

Received for publication, December 11, 2002 , and in revised form, March 20, 2003.
    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
In mating mixtures of Saccharomyces cerevisiae, cells polarize their growth toward their conjugation partners along a pheromone gradient. This chemotropic phenomenon is mediated by structural proteins such as Far1 and Bem1 and by signaling proteins such as Cdc24, Cdc42, and G{beta}{gamma}. The G{beta}{gamma} subunit is thought to provide a positional cue that recruits the polarity establishment proteins, and thereby induces polarization of the actin cytoskeleton. We identified RHO1 in a screen for allelespecific high-copy suppressors of G{beta}{gamma} overexpression, suggesting that Rho1 binds G{beta}{gamma} in vivo. Inactivation of Rho1 GTPase activity augmented the rescue phenotype, suggesting that it is the activated form of Rho1 that binds G{beta}{gamma}. We also found, in a pull-down assay, that Rho1 associates with GST-Ste4 and that Rho1 is localized to the neck and tip of mating projections. Moreover, a mutation in STE4 that disrupts G{beta}{gamma}-Rho1 interaction reduces the projection tip localization of Rho1 and compromises the integrity of pheromone-treated cells deficient in Rho1 activity. In addition to its roles as a positive regulator of 1,3-{beta}-glucan synthase and of the cell integrity MAP kinase cascade, it was recently shown that Rho1 is necessary for the formation of mating projections. Together, these results suggest that G{beta}{gamma} recruits Rho1 to the site of polarized growth during mating.


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Signal-induced polarized growth is a fundamental mechanism of cellular differentiation and environmental response. The function of many mammalian cell types depends on their ability to sense relevant stimuli and grow in a directed fashion. An excellent model system with which to study such chemotropic phenomena is the mating response of the budding yeast, Saccharomyces cerevisiae. In preparation to mate, haploid yeast of opposite mating types exchange peptide mating pheromones. The binding of pheromone to G protein-coupled receptors triggers a developmental program that ultimately blocks cell cycle progression, alters gene expression, and induces the formation of elongated projections called shmoos. These mating projections grow toward the highest concentration of pheromone and are crucial for the establishment of cell fusion (1, 2). It has recently become clear that the receptor and the G protein are the sensors of the pheromone gradient (3, 4). Chemotropic growth depends on the association between free G{beta}{gamma} and the guanine nucleotide exchange factor Cdc24 through the intermediary scaffold Far1 (5, 6). Cdc24 activates the monomeric G protein, Cdc42 (6, 7), which polarizes the actin cytoskeleton and thus the growth of the plasma membrane (8). In S. cerevisiae, the plasma membrane is supported by a rigid cell wall composed of polysaccharides and mannoproteins (9). Presumably, growth of the plasma membrane requires growth of the cell wall. The biosynthesis of cell wall components is tightly coordinated with the construction of new cell wall (9). This coordination is partially dependent on Rho1, a monomeric G protein belonging to the same GTPase subfamily as Cdc42. Rho1 plays a dual role in cell wall biosynthesis. First, Rho1 is a regulatory subunit of the glucan synthase enzymatic complex (10). It regulates the synthesis of 1,3-{beta}-glucan, the major component of the yeast cell wall. Second, Rho1 binds and activates the protein kinase C of yeast, Pkc1. Rho1-dependent Pkc1 activation initiates a MAP1 kinase signaling cascade that is critical to the maintenance of cell wall integrity when the cell is stressed (1114). Here we show that in addition to stimulating polarized growth of the plasma membrane by recruiting Cdc42, G{beta}{gamma} also associates with Rho1. This association is required for proper localization of Rho1 to the tip of the mating projection.


    EXPERIMENTAL PROCEDURES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Molecular and Microbiological Techniques—Standard methods were used for microbial and molecular manipulation (15, 16). The rho1ts yeast strain used in the cell lysis experiment was isolated by Saka et al. (43). All other yeast strains used in this study were derived from strain 15Dau (MATa bar1{Delta} ade1 his2 leu2–3,-112 trp1 ura3{Delta}), which is isogenic with strain BF264 –15D (17). Both strains A35 and ELY115 contain the STE4A405V allele at the STE4 locus. Strain A35 is the original mutant STE4 isolate (18). It was back-crossed three times prior to use in this study. Strain ELY115 was created by replacing STE4 with STE4A405V in the wild type 15Dau background (18). Yeast transformations were preformed by the lithium acetate method (19). Escherichia coli transformations were preformed by electroporation (16). The plasmids used in this study are listed in Table I. Plasmids YCplac33/GAL1-STE4 and YCplac33/GAL1-STE4A405V were constructed as follows: STE4 was PCR-amplified from YCplac33/STE4 and YCplac33/STE4A405V (18) with added BamHI-EcoRI ends. The priming oligonucleotides were: 5'-CGGGATCCCTGTACAGCTCAATCA-3' and 5'-CG-GAATTCGTAGGGACAGCCATCATG-3' (boldface letters indicate the bases that comprise the added restriction sites). The products were subcloned into the pCRII vector (Invitrogen), and subsequently subcloned as BamHI fragments into YCpLac33/GAL. PYES2.0/GAL1-RHO1 was created as follows: RHO1 was PCR-amplified using strain 15Dau genomic DNA as template, and the product was cloned into the pYES2.0 vector (Invitrogen) as a BamHI-EcoRI fragment. The priming oligonucleotides were: 5'-CGGGTACCTGCACTAATAGAAAATCATAGAAC-3' and 5'-GGGAATTC AAAGGCATACGTACATACAATAGA-3'. pEB15.0 was created as follows: RHO1 was PCR-amplified from strain 15Dau genomic DNA, and the product was cloned into pESC-URA (Stratagene, La Jolla, CA) as a KpnI-XhoI fragment, thereby placing RHO1 under GAL1 promoter control. The priming oligonucleotides were: 5'-CCGCTCGAGATGTCACAACAAG TTGGTAAC-3' and 5'-CGGGGTACCCTATAACAAGACACATTTC-3'. FAR1 was PCR-amplified from strain 15Dau genomic DNA, and the product was cloned into pESC-URA as a PacI-BglII fragment, thereby placing FAR1 under GAL10 promoter control. The priming oligonucleotides were: 5'-CCTTAATTAAGCGTAGTATAGACGTGGAG-3' and 5'-GAAGATCTTGAAGACACCAACAAGAGTTTCG-3'. pEB13.0 was created as follows: STE4 was PCR-amplified from 15Dau genomic DNA, and the product was cloned into pYEX4T-1 (Clontech Lab. Palo Alto, CA) as an EcoRI fragment. The priming oligonucleotides were: 5'-CGGAATTCATGGCAGCACATCAGATGG-3' and 5'-GAATTCCACAGTATTTCCAATTCG-3'. The resulting CUP1-GST-STE4 hybrid gene was then excised as a PvuII-NdeI fragment. Its ends were blunted using Klenow fragments and subcloned into PvuII-digested YCplac111. pEB13.2 was created by subcloning the blunt-ended PvuII-NdeI CUP1-GST fragment from pYEX4T-1 to YCplac111. pEB13.1 was created by converting the wild type STE4 allele of pEB13.0 to STE4A405V using the QuikChangeTM mutagenesis kit (Stratagene). The mutagenic primers were: 5'-GTCCAGATGGGTTAGTTGTATGTACAGGTTCA-3' and 5'-CCTGTACATACAACTAACCCATCTGGACTCG-3' (the mutagenic bases are indicated in boldface and underlined). pEB13.5 was created as follows: PKC1378–640 (PKC1RID) was PCR-amplified from pGAD424/ PKC1. The priming oligonucleotides were: 5'-GCGAAGATCTACACTAGGATTCCACAAGTC-3' and 5'-CCGCTCGAGCGGGGCCTCATTTTCATCGA-3'. The PCR product was digested with BglII and XhoI and subcloned into BamHI/XhoI-digested pEB13.2. pEB18.0 was created as follows: PKC1RID was PCR-amplified from pGAD424/PKC1. The priming oligonucleotides were: 5'-TCCCCGCGGGGAATGACACTAGGATTCCACAAGTC-3' and 5'-TCCCCGCGGGGACTCATTTTCATCGATAAATTTATTTAG-3'. The PCR product was digested with SacII and ligated to SacII-digested pRS316CG. YCplac22/GAL1-His6-STE18 was created as follows: STE18 was PCR-amplified from 15Dau genomic DNA. The priming oligonucleotides were: 5'-GGATCCATGCATCACCATCACCATCACATGACATCAGTTCAAAACTC TCCACGC-3' and 5'-GAAGCTTTTACATAAGCGTACAACAAACAC-3'. The PCR product was ligated into PCRII (Invitrogen), and subsequently subcloned into YCplac22/GAL1 as a BamHI-HindIII fragment. The GAL1-RHO1 transcriptional fusion identified in the screen was isolated from a cDNA library kindly provided by Stephen J. Elledge. Plasmids pRS315/RHO1, pRS425/RHO1, pRS315/RHO1Q68H, and pRS425/RHO1Q68H were kindly provided by Alan M. Myers (20).


View this table:
[in this window]
[in a new window]
 
TABLE I
Plasmids used in this study

 

{beta}{gamma} Allele-specific High-copy Suppressor Screen—Strain ELY105 (a derivative of strain 15Dau containing an integrated copy of GAL1-STE18) was transformed first with YCplac33/GAL1-STE4 and subsequently with the yeast pTRP1 c-DNA library (kindly provided by Stephen Elledge). Transformants were spread on selective sucrose medium lacking uracil and tryptophan. Approximately 100,000 colonies were then replica-plated to selective dextrose or to selective galactose medium lacking uracil and tryptophan. Rescue of growth arrest was verified, and sterile mutants were discarded. The YCpLac33/GAL1-STE4 plasmid was cured using 5-fluoroorotic acid, and the strains were transformed with YCplac33/GAL1-STE4A405V. The ability of the library clone to rescue overexpression of STE4A405V was then determined. Library clones that showed allele specificity were characterized further.

Colony Formation Assays—Colony formation assays were performed by spreading 750 cells on the appropriate selective medium containing a range of {alpha}-factor concentrations. Plates were incubated at 30 °C for 3–5 days. Resistance to {alpha}-factor was quantified by determining the percent survival on medium containing 3, 6, 15, 30, and 60 nM {alpha}-factor as compared with the number of colonies that formed on medium lacking pheromone.

FUS1 Expression Assays—Expression of the pheromone-inducible FUS1 transcript was assayed by measuring {beta}-galactosidase levels in cells containing a FUS1-lacZ reporter gene. Strain 15Dau was transformed with the FUS1-LacZ reporter vector (pSB231) (21) and either pYES2 or pYES2/GAL1-RHO1. Cultures were grown at 30 °Ctoan A600 of 0.5 in selective galactose medium. {alpha}-Factor was added to a final concentration of 15 nM, and the cultures were shaken at 30 °C. Cells were harvested, and {beta}-galactosidase activity was determined as described previously (22). To assay {beta}-galactosidase in cells grown on solid medium, nitrocellulose lift assays were performed as described (23).

Immunoblots—Yeast whole cell extracts were prepared by bead beating and clarified by centrifugation. 15 µg of total protein/well was electrophoresed on discontinuous SDS-polyacrylamide gels and electro-blotted to polyvinylidene difluoride membranes (PVDF-PLUS, MSI Inc., Westborough, MA) according to the manufacturer's protocol. Blots were then blocked with 5% nonfat dry-milk in TBS (20 mM Tris-HCl, pH 7.5, 500 mM NaCl) for 1 h and incubated with a 1:2000 dilution of a rabbit anti-GST antibody (Santa Cruz Biotechnology. Inc., Santa Cruz, CA) or a 1:500 dilution of the 9E10 mouse anti c-Myc antibody (Santa Cruz). Membranes were incubated at 4 °C overnight and then washed three times with TBS plus 0.2% Tween for 10 min. The washed membranes were probed with either horseradish peroxidase-conjugated goat anti-rabbit antibody (Promega, Madison, WI) or horseradish peroxidase-conjugated sheep anti-mouse antibody (Amersham Biosciences). Membranes were washed three times with TBS plus 2% Tween, and peroxidase activity was visualized using ECL (Amersham Biosciences) and Fuji RX film (Fuji Medical Systems, Stanford, CT).

GST Pull-down—Yeast strains EBY185, EBY186, and EBY187 were derived from strain 15Dau by transformation. They each carry the YCplac22/GAL1-His6-STE18 and pEB15.0 plasmids. In addition, EBY185 carries the pEB13.0 plasmid, EBY186 carries the pEB13.1 plasmid, and EBY187 carries the pEB13.2 plasmid. All three strains were grown in selective medium at 30 °C to an A600 of 0.4, at which point galactose was added to a final concentration of 3%. Cultures were then split and incubated for 2 h at 30 °C. {alpha}-Factor was added to a final concentration of 15 nM, and the cultures were incubated for an additional 4 h. Cells were visualized by phase-contrast light microscopy to confirm mating projection formation in the treated cultures. Cells were harvested by centrifugation, washed once with cold water, and frozen in liquid nitrogen. Upon thawing, cell pellets were washed once with TBS and lysed with glass beads in radioimmune precipitation buffer (50 mM Tris, pH 7.5, 1% sodium deoxycholate, 1% Triton X-100, 1 mM NaPPi, 150 mM NaCl, 1 mM Na3VO4, 50 mM NaF). Protease inhibitors were added just before lysis: 1 mM phenylmethylsulfonyl fluoride (Roche Applied Science), 1 µg/ml pepstatin A, 1 µg/ml leupeptin, and 5 µg/ml aprotinin (Sigma). The crude lysates were cleared by centrifugation at 12,000 rpm for 15 min. Protein concentration was determined using the Bio-Rad protein assay kit. For each sample, 1 mg of total protein was transferred to a chilled microcentrifuge tube containing 20 µl of glutathione-Sepharose 4B (Amersham Biosciences); the tubes were incubated for 30 min at room temperature and then for an additional 30 min at 4 °C. The beads were washed several times with phosphate-buffered saline supplemented with the protease inhibitor mixture described above. To elute the bound proteins, 50 µl of sample loading buffer was added, and the samples were boiled for 3 min. Samples were subjected to SDS electrophoresis.

Immunofluorescence—Strains 15Dau, A35, and ELY115 were transformed with pHA-RHO1 and grown to mid-log phase in selective medium at 30 °C. The localization of HA-Rho1 was determined by immunofluorescence before and 2 h after treatment with 30 nM {alpha}-factor. Cells were prepared for immunofluorescent microscopy as described previously (15). The primary antibody, 12CA5 (Roche Diagnostics), was incubated with the immobilized cells at a dilution of 1:500, and the fluorescein isothiocyanate-conjugated anti-mouse secondary antibody (Santa Cruz) was diluted 1:2000. Fluorescent images were acquired using a Zeiss Axioskop 2 microscope fitted with a Zeiss AxioCam digital camera and processed using Zeiss AxioVision software.

PKC1RID-GFP Visualization—Strains 15Dau, A35, and ELY115 were transformed with pEB18.0 and grown to mid-log phase in selective medium at 30 °C. The expression of PKC1RID-GFP was induced by adding CuSO4 to a concentration of 0.5 mM. The localization of Pkc1RID-GFP was visualized before and 2 h after treatment with 30 nM {alpha}-factor. Live cells were scored for the presence of Pkc1RID-GFP at the mating projection tip using a Zeiss Axioskop 2 microscope.

Photomicrographs and Quantification of HA-Rho1 Localization— Fluorescent images were acquired using a Zeiss Axioskop 2 microscope fitted with a Zeiss AxioCam digital camera and processed using Zeiss AxioVision software. Localization of HA-Rho1 was quantified from the digital images using the histogram function of Adobe Photoshop, version 5.5. A circle of set size was used to sample the brightness of the projection tip and a peripheral point directly opposite the tip of cells from randomly chosen fields. The ratio of tip to bottom fluorescence was rounded to the nearest 0.1, and values corresponding to 50 cells for each strain were plotted in histograms.

Cell Lysis Assay—Cells were grown at 23 °C in selective media to a density of A600 = 2.5, and then 4 ml of each culture was harvested and resuspended in 1 ml of rich medium (YEPD medium, containing 1% yeast extract (Difco Laboratories), 2% Bacto-Peptone (Difco), and 2% glucose). After incubation at 23 °C for 4 h, the cells were pelleted again and resuspended in 40 µl of YEPD. 10 µl of each suspension was spotted onto YEPD plates and on YEPD plates supplemented with 150 nM {alpha}-factor. After incubation at room temperature overnight, the lysis assay was performed as described previously (24). Digital images of the plates were acquired after 2 h at room temperature.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Rho1 Associates with Ste4 —On the basis of genetic and structural evidence, we have inferred that an unknown protein binds and down-regulates the {beta}{gamma} subunit of the pheromone responsive G protein. G{beta} and G{gamma} are encoded by the STE4 and STE18 loci, respectively. A tight cluster of mutations in STE4 (A405V, G409D, S410L, and W411L/S) disrupts interaction with the putative regulator (18). To identify the unknown element, we took advantage of the observation that G{beta}{gamma} overexpression strongly induces the mating signal and thereby confers permanent cell cycle arrest (2527). Plasmids were constructed that allow for the galactose-inducible expression of G{beta} (GAL1-STE4) and G{gamma} (GAL1-STE18). A high-copy GAL1-cDNA yeast library was then screened for plasmids that could rescue the overexpression of wild type G{beta}{gamma}. Plasmids recovered in this step were re-screened for the inability to rescue the overexpression of a mutant form of G{beta}{gamma}, encoded by STE4A405V and STE18. We reasoned that genes identified in this allele-specific screen might encode proteins that interact with Ste4. Of the 250,000 transformants screened, the most frequently isolated plasmid contained RHO1. Rho1 is a highly conserved and well studied monomeric G protein. The mammalian homologue of Rho1, RhoA, is involved in polarization of the actin cytoskeleton. It has also been implicated in transcription, adhesion, and transformation (2830). Like mammalian Rho proteins, Rho1 is thought to play a role in polarization of the actin cytoskeleton (10, 31). However, it also stimulates 1,3-{beta}-glucan synthase (10, 32) and the cell integrity MAP kinase cascade (33, 34), both of which are necessary for growth of the yeast cell wall.

To confirm and quantitate the effect of Rho1 overexpression on G{beta}{gamma}-induced lethality, we performed single-colony formation assays. Strain 15Da (17) was co-transformed with either the wild type or mutant G{beta}{gamma}-overexpressing plasmids and either RHO1 low-copy, RHO1 high-copy, or control plasmids. Transformants were plated on glucose and on galactose medium, respectively, to repress and induce expression of G{beta}{gamma}. Only about 0.5% of the cells overexpressing wild type G{beta}{gamma} in the absence of excess Rho1 were able to form colonies (Fig. 1A). In contrast, about 5% of the cells transformed with the low-copy number RHO1 plasmid and about 13% of the cells transformed with the high-copy number RHO1 plasmid could overcome the excess G{beta}{gamma} and form colonies. Interestingly, overexpression of a mutationally activated form of Rho1, RHO1Q68H, enhanced the rescue phenotype by about 3-fold. However, neither Rho1 nor Rho1Q68H could significantly increase the plating efficiency of cells forced to overexpress the mutant form of G{beta}{gamma}. The simplest interpretation of these data is that excess Rho1 antagonizes G{beta}{gamma}-induced cell cycle arrest by directly interacting with Ste4. A less likely possibility is that Rho1 rescues cells overexpressing G{beta}{gamma} by promoting cell cycle progression rather than by relieving the inhibitory effects of the mating signal. To distinguish these hypotheses, we assessed the effect of Rho1 overexpression on mating specific transcription using a FUS1-lacZ reporter. The reporter was stimulated either by treating cells with pheromone or by expression of Ste11-4, a dominant mutant form of the Ste11 MEK kinase that constitutively activates the mating pathway (35). Excess wild type Rho1 reduced pheromone-induction of FUS1-lacZ by about 50% (Fig. 1B) but had no effect on the activity of Ste11-4 (Fig. 1C). Thus, Rho1 overexpression inhibits the effects of free G{beta}{gamma} on both transcription and cell cycle progression, and it does so at or above the level of the MEK kinase.



View larger version (24K):
[in this window]
[in a new window]
 
FIG. 1.
The effect of Rho1 activation and overexpression on mating pathway signaling. A, colony formation assays. Strain 15Dau was cotransformed with either the GAL1-STE4 (closed bars) or GAL1-STE4A405V (open bar) plasmids, along with low-copy (CEN) or high-copy (2µ) RHO1 plasmids. Rho1* indicates the activated (Q68H) form of RHO1. Transformants were grown to saturation in galactose medium, and the relative ability of each strain to form colonies was determined as described under "Experimental Procedures." B, pheromone-induced transcription assay. Strain 15Dau was cotransformed with either the pYES2.0/Gal1-Rho1 or pYES2.0 plasmids along with the FUS1-lacZ reporter plasmid, pSB231. Transformants were grown to mid-log phase in galactose medium and treated with 15 nM {alpha}-factor. Aliquots were taken at the indicated time points, and {beta}-galactosidase activity was determined as described under "Experimental Procedures." The closed bars correspond to the pYES2.0 cells and the open bars to the pYES2.0/Gal1-Rho1 cells. C, epistasis analysis. 15Dau cells transformed with pSB231 and the following plasmids were grown to saturation on solid medium containing galactose: left, GAL1-STE4; middle, STE11-4 and GAL1-RHO1; right, GAL1-STE4 and GAL1-RHO1. {beta}-Galactosidase activity was then assayed as described under "Experimental Procedures."

 

To further evaluate the possibility that G{beta}{gamma} physically interacts with Rho1, we constructed tagged versions of Ste4, Ste18, and Rho1, and performed pull-down assays. The tagged forms of all three proteins proved to be functional (data not shown). As shown in Fig. 2, myc-Rho1 specifically associated with GSTSte4 but failed to associate with GST-Ste4A405V or GST alone. Interestingly, the Far1 protein, which links G{beta}{gamma} with Bem1 and Cdc42, also failed to associate with GST-Ste4A405V (data not shown).



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 2.
Association of Rho1 with Ste4. Lysates of 15Dau overexpressing cMyc-Rho1, His6-Ste18, and either GST-Ste4 (first and second lanes from left), GST-Ste4A405V (third and fourth lanes), or GST (fifth lane) were incubated with glutathione beads. The bound proteins were resolved on SDS-PAGE and immunoblotted with anti-GST (upper panel), and anti-cMyc (lower panel). B, bound proteins; L, protein load.

 

The Localization of Rho1 to the Tips of Mating Projections Depends on Ste4 —In dividing cells, Rho1 associates with cortical actin patches, concentrating at the site of bud emergence, the tip of growing buds, and the mother-bud neck region prior to cytokinesis (31, 36). This subcellular localization of Rho1 is consistent with its role in stimulating cell wall biogenesis through interaction with 1,3-{beta}-glucan synthase and Pkc1. Given that G{beta}{gamma} concentrates at the tips of mating projections (37), and that G{beta}{gamma} and Rho1 interact (Figs. 1 and 2), we would expect to find Rho1 at the tips of mating projections as well. Indeed, Rho1 has been reported to exhibit "polarized localization" when stationary cells are treated with pheromone (38). To confirm and extend this observation, we examined the localization of an HA-tagged form of Rho1 (39). As expected, HA-Rho1 was found at the periphery of vegetative cells and was concentrated at the tips of mating projections after pheromone treatment (Fig. 3A). We also observed HA-Rho1 in a ring at the mating projection neck (data not shown). To determine whether the shmoo tip localization of Rho1 depends on its association with Ste4, we compared the localization of HARho1 in wild type and STE4A405V cells (Fig. 3, A and B). Although the two strains exhibited identical HA-Rho1 staining patterns during vegetative growth, HA-Rho1 was clearly mislocalized in a large fraction of the STE4A405V cells following pheromone treatment. Whereas ~72% of the responsive wild type cells showed a detectable concentration of HA-Rho1 at the shmoo tip, tip localization was apparent in only about 25% of the mutant cells. Furthermore, the fraction of mutant cells in which HA-Rho1 did localize to the projection tips exhibited significantly less polarized accumulation of the reporter than did the wild type cells. A quantitative assay showed the tips of the wild type shmoos to be, on average, twice as bright as their bottoms, whereas the average mutant shmoo was only 40% brighter at its tip than at its bottom (Fig. 3C). t test analysis of the data showed this difference to be highly significant (p < 0.0001). STE4A405V cells are supersensitive to pheromone (18), and thus these results cannot be attributed to poor responsiveness or, as shown in Fig. 3D, to a low level of HA-Rho1. Therefore, the reduced tip localization of HA-Rho1 in STE4A405V cells indicates that G{beta}{gamma} plays a role in recruiting Rho1 to the site of polarized growth in mating cells.



View larger version (34K):
[in this window]
[in a new window]
 
FIG. 3.
Localization of Rho1 before and after pheromone treatment. 15Dau cells transformed with pHA-RHO1 were grown to mid-log phase, and the localization of HA-Rho1 was determined by immunofluorescence before and 2 h after treatment with 30 nM {alpha}-factor. Aliquots were also taken to determine the relative levels of HA-Rho1 in each culture. A, representative photomicrographs of wild type (strain DSY257) and STE4A405V (strain A35) cells. B, bar graphs indicating the percent wild type (strain DSY257) and STE4A405V (strain A35) cells that showed a detectable concentration of HA-Rho1 at the shmoo tip. The mean values and standard deviations were calculated from three independent experiments. C, quantitation of the relative HA-Rho1 concentration at shmoo tips. The relative tip fluorescence for populations of wild type and STE4A405V cells was determined as described under "Experimental Procedures," and the distribution of values represented in histograms. The number of cells (y axis) is plotted as a function of the relative tip fluorescence values (x axis). The arrows on the histograms indicate the mean value for each of the sampled populations. D, Western blot showing the relative levels of HA-Rho1 in the wild type (strain DSY257) and STE4A405V mutant (strain A35) cells used in the localization experiments. Aliquots were taken for analysis before (t = 0) and 2 h after (t = 2) treatment with pheromone.

 

Because inactivating the GTPase function of Rho1 augments its ability to rescue G{beta}{gamma} overexpression (Fig. 1A), we wondered whether G{beta}{gamma} preferentially associates with the activated form of Rho1. To answer this question, we took advantage of the finding that an internal domain of Pkc1, residues 378–640, specifically binds to activated Rho1 in the two-hybrid assay (40). We fused this Rho1 interaction domain (RID) in-frame with the gene encoding green fluorescence protein (GFP). The resulting reporter, Pkc1RID-GFP, was then used to probe the subcellular localization of active Rho1. An analogous reporter was used to monitor the localization of active Rac1 (41), another monomeric G protein of the Rho class. Surprisingly, Pkc1RID-GFP concentrated in the nuclei of vegetative cells (Fig. 4A). When cells were stimulated with pheromone, however, Pkc1RID-GFP concentrated at the tips of the mating projections (Fig. 4A), perfectly mimicking the staining pattern of HA-Rho1 under the same conditions (Fig. 3A). We next compared the localization of Pkc1RID-GFP in wild type and STE4A405V cells responding to pheromone. As we found when assaying the localization of HA-Rho1, the localization of Pkc1RID-GFP to the tips of mating projections was significantly reduced in the mutant cells (Fig. 4B). This result suggests that it is the activated form of Rho1 that associates with G{beta}{gamma} at the shmoo tip.



View larger version (35K):
[in this window]
[in a new window]
 
FIG. 4.
Localization of Pkc1RID-GFP. 15Dau cells transformed with pEB18.0 (PKC1RID-GFP) were grown to mid-log phase, and the localization of Pkc1RID-GFP was determined by fluorescent microscopy before and 2 h after treatment with 30 nM {alpha}-factor. A, representative photomicrographs of wild type (strain DSY257) cells. B, bar graphs indicating the percent wild type (strain DSY257) and STE4A405V (strain A35) cells that showed a detectable concentration of Pkc1RID-GFP at the shmoo tip. The mean values and standard deviations were calculated from three independent experiments.

 

STE4A405V and rho1–4 Confer a Synthetic Defect in the Integrity of Pheromone-treated Cells—Rho1 is essential for projection formation (31), presumably because it is essential for cell wall synthesis at the shmoo tip. If recruitment of Rho1 to the growth site is necessary for this process, then how are STE4A405V cells able to shmoo? First, it is clear that STE4A405V cells are only partially defective in localizing Rho1 to the shmoo tip. Perhaps the mutant form of G{beta}{gamma} is not completely deficient in Rho1 recruitment, or perhaps Rho1 is attracted by additional factors at the growth site. Second, Sekiya-Kawasaki et al. (42) have recently found that only about 20% of the normal 1,3-{beta}-glucan synthase activity is required for viability (Table 3 in Ref. 42), suggesting that the synthesis of 1,3-{beta}-glucan is not limiting. The abundance of 1,3-{beta}-glucan synthase activity may mask the functional significance of the G{beta}{gamma}-Rho1 interaction during mating projection formation. To test this possibility, we used a rho1 temperature-sensitive strain, YOC754 (43), which manifests a 5-fold reduction in Rho1 activity at room temperature. The native copy of STE4 was deleted in YOC774, and the ste4{Delta} derivative strain was transformed with centromeric vectors containing STE4 and STE4A405V. We expected the combination of STE4A405V and low Rho1 activity to confer a defect in cell wall biosynthesis at the tips of mating projections and, ultimately, a loss of cell integrity. Loss of cell integrity can be detected easily by overlaying cell patches with a solution containing 5-bromo-4-chloro-3-indoyl phosphate, a colorimetric substrate that is cleaved to a blue product by the alkaline phosphatase released from cells upon lysis. For reasons that are not clear, the rho1ts strain and its ancestral wild type strain (YOC1943) form mating projections very inefficiently. Only about 5% of these cells shmoo in response to 150 nM {alpha}-factor. Nevertheless, despite minimal induction of polarized growth, the combination of the rho1ts and STE4A405V alleles conferred a pheromone-induced increase in cell lysis (Fig. 5). Neither the rho1ts nor the STE4A405V single-mutant strains exhibited increased lysis upon pheromone treatment. Thus, there is a critical threshold of Rho1 recruitment to the shmoo tip below which cell integrity is compromised.



View larger version (45K):
[in this window]
[in a new window]
 
FIG. 5.
Effect of rho1–4 and STE4A405V on cell integrity. Cells were grown and assayed for lysis as described under "Experimental Procedures." Vegetative cells are shown in the upper row. Pheromonetreated cells are shown in the lower row. From left to right, the strains are as follows: 1) wild type (YOC1943); 2) ELY112, an STE4A405V derivative of strain 15dau (18); 3) EBY246, a derivative of strain YOC774 (43) of relevant genotype rho1–4 ste4{Delta} YCplac33/STE4; 4) EBY247, a derivative of strain YOC774 of relevant genotype rho1–4 ste4{Delta} YCplac33/STE4A405V. The results of this experiment were identical in three independent trials.

 


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 
Signal-induced polarization is essential in development and in the differentiated function of many cell types. For example, neuronal growth cones respond to chemoattractants during nervous system development (44), fibroblasts move toward locally released platelet-derived growth factor during wound healing (45), and cell migration is guided by epidermal growth factor receptor signaling during Drosophila oogenesis (46). In vegetative yeast cells, growth is polarized toward the daughter cell by internal cues. Upon pheromone treatment, the axis of polarity is reoriented in response to the chemical gradient. Free G{beta}{gamma} binds to Far1, which acts as a scaffold on which Cdc24, Cdc42, and Bem1 are assembled. This complex is thought to polarize the actin cytoskeleton so that the plasma membrane grows toward the source of pheromone. In order for the cell to elongate, however, the cell wall must grow along with the plasma membrane, a process that requires Rho1.

Two previous studies have demonstrated direct interaction between RhoA, a mammalian homologue of Rho1, and G{beta} subunits (47, 48). However, the functional importance of the G{beta}-Rho interaction was not elucidated in either study. More recently, Thodeti et al. (49) discovered an agonist-induced association between G{beta}{gamma} and active RhoA in solubilized membrane fractions from mammalian cells; they inferred that G{beta}{gamma} participates in targeting active RhoA to the plasma membrane. We have found that Rho1 interacts with Ste4 (G{beta}) in an allele-specific manner: The activated form of Rho1 associates with the wild type but not the STE4A405V mutant form of G{beta}{gamma}. By studying the effects of disrupting Ste4-Rho1 association on intact yeast cells, we have demonstrated the functional importance of a G{beta}{gamma}-Rho interaction. STE4A405V cells show a significant decrease in the localization of activated Rho1 localization to the mating projection tip. Therefore, the G{beta}{gamma} of yeast recruits Rho1 to a particular membrane domain in response to an external signal. Given the known functions of Rho1, its association with G{beta}{gamma} could serve either of two purposes. Recruitment to the growth site during pheromone-induced projection formation would concentrate Rho1 in the place where stimulation of 1,3-{beta}-glucan synthase activity is needed. Alternatively, G{beta}{gamma} might help position Rho1 in the vicinity of Pkc1, thereby facilitating Rho1 stimulation of the cell integrity MAP kinase cascade. In fact, pheromone induction of the Mpk1 MAP kinase requires Ste4 (50), and Rho1 is required to localize Pkc1 to sites of polarized growth (51). In either case, we would expect G{beta}{gamma}-Rho1 coupling to contribute to the chemotropic growth of the cell wall during mating. Consistent with this hypothesis, STE4A405V compromises the integrity of pheromone-treated cells, which are partially deficient in Rho1 activity (Fig. 5). An intriguing possibility is that the recruitment of both Rho1 and Cdc42 to the pheromone-induced site of polarized growth by G{beta}{gamma} serves to coordinate cell wall and plasma membrane biosynthesis in time and space.


    FOOTNOTES
 
* This work was supported by American Cancer Society Research Grant RPG-94-034-06-MBC and by National Science Foundation Grant MCB-0111 397. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. Back

{ddagger} To whom correspondence should be addressed. Tel.: 312-996-5710; Fax: 312-413-2691; E-mail: dstone{at}uic.edu.

1 The abbreviations used are: MAP, mitogen-activated protein; MEK, mitogen-activated protein kinase/extracellular signal-regulated kinase kinase; GST, glutathione S-transferase; TBS, Tris-buffered saline; HA, hemagglutinin; GFP, green fluorescent protein; RID, Rho1 interaction domain. Back


    ACKNOWLEDGMENTS
 
We thank Stephen Elledge for providing the lambda yeast cDNA library; Michael Hall, Yoshimi Takai, and Yoskikazu Ohya for providing RHO1 strains and plasmids; Grace Park for technical assistance; and members of the Stone laboratory for critical reading of the manuscript.



    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 EXPERIMENTAL PROCEDURES
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Segall, J. E. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 8332–8336[Abstract/Free Full Text]
  2. Valtz, N., Peter, M., and Herskowitz, I. (1995) J. Cell Biol. 131, 863–873[Abstract]
  3. Schrick, K., Garvik, B., and Hartwell, L. H. (1997) Genetics 147, 19–32[Abstract/Free Full Text]
  4. Metodiev, M. V., Matheos, D., Rose, M. D., and Stone, D. E. (2002) Science 296, 1483–1486[Abstract/Free Full Text]
  5. Butty, A. C., Pryciak, P. M., Huang, L. S., Herskowitz, I., and Peter, M. (1998) Science 282, 1511–1516[Abstract/Free Full Text]
  6. Nern, A., and Arkowitz, R. A. (1999) J. Cell Biol. 144, 1187–1202[Abstract/Free Full Text]
  7. Nern, A., and Arkowitz, R. A. (1998) Nature 391, 195–198[CrossRef][Medline] [Order article via Infotrieve]
  8. Adams, A. E., Johnson, D. I., Longnecker, R. M., Sloat, B. F., and Pringle, J. R. (1990) Mol. Cell. Biol. 111, 131–142
  9. Klis, F. M. (1994) Yeast 10, 851–869[Medline] [Order article via Infotrieve]
  10. Drgonova, J., Drgon, T., Tanaka, K., Kollar, R., Chen, G.-C., Ford, R. A., Chan, C. S. M., Takai, Y., and Cabib, E. (1996) Science 272, 277–279[Abstract]
  11. Levin, D. E., and Bartlett-Heubusch, E. (1992) J. Cell Biol. 116, 1221–1229[Abstract]
  12. Lee, K. S., Irie, K., Gotoh, Y., Watanabe, Y., Araki, H., Nishida, E., Matsumoto, K., and Levin, D. E. (1993) Mol. Cell. Biol. 13, 3067–3075[Abstract]
  13. Errede, B., and Levin, D. E. (1993) Curr. Opin. Cell Biol. 5, 254–260[Medline] [Order article via Infotrieve]
  14. Levin, D. E., Bowers, B., Chen, C. Y., Kamada, Y., and Watanabe, M. (1994) Cell. Mol. Biol. Res. 40, 229–239[Medline] [Order article via Infotrieve]
  15. Guthrie, C., and Fink, G. R. (eds) (1991) Guide to Yeast Genetics and Molecular Biology, Academic Press, San Diego, CA
  16. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A., and Struhl, K. (1994) Current Protocols in Molecular Biology (Janssen, K., ed) John Wiley and Sons, Inc., New York
  17. Reed, S. I., Hadwiger, J. A., and Lorincz, A. T. (1985) Proc. Natl. Acad. Sci. U. S. A. 82, 4055–4059[Abstract]
  18. Li, E., Meldrum, E., Stratton, H., and Stone, D. E. (1998) Genetics 148, 947–961[Abstract/Free Full Text]
  19. Ito, H., Fukuda, Y., Murata, K., and Kimura, A. (1983) J. Bacteriol. 153, 163–168[Medline] [Order article via Infotrieve]
  20. Madaule, P., Axel, R., and Myers, A. M. (1987) Proc. Natl. Acad. Sci. U. S. A. 84, 779–783[Abstract]
  21. Trueheart, J., Boeke, J. D., and Fink, G. R. (1987) Mol. Cell. Biol. 7, 2316–2328[Medline] [Order article via Infotrieve]
  22. Slater, M. R., and Craig, E. A. (1987) Mol. Cell. Biol. 7, 1906–1916[Medline] [Order article via Infotrieve]
  23. Breeden, L., and Nasmyth, K. (1987) Cell 48, 389–397[Medline] [Order article via Infotrieve]
  24. Paravicini, G., Cooper, M., Friedli, L., Smith, D. J., Carpentier, J. L., Klig, L. S., and Payton, M. A. (1992) Mol. Cell. Biol. 12, 4896–4905[Abstract]
  25. Cole, G. M., Stone, D. E., and Reed, S. I. (1990) Mol. Cell. Biol. 10, 510–517[Medline] [Order article via Infotrieve]
  26. Nomoto, S., Nakayama, N., Arai, K.-I., and Matsumoto, K. (1990) EMBO J. 9, 691–696[Abstract]
  27. Whiteway, M., Hougan, I., and Thomas, D. Y. (1990) Mol. Cell. Biol. 10, 217–222[Medline] [Order article via Infotrieve]
  28. Narumiya, S. (1996) J. Biochem. (Tokyo) 120, 215–228[Abstract]
  29. Kimura, K., Ito, M., Amano, M., Chihara, K., Fukata, Y., Nakafuku, M., Yamamori, B., Feng, J., Nakano, T., Okawa, K., Iwamatsu, A., and Kaibuchi, K. (1996) Science 273, 245–248[Abstract]
  30. Sahai, E., Olson, M. F., and Marshall, C. J. (2001) EMBO J. 20, 755–766[Abstract/Free Full Text]
  31. Drgonova, J., Drgon, T., Roh, D.-H., and Cabib, E. (1999) J. Cell Biol. 146, 373–387[Abstract/Free Full Text]
  32. Qadota, H., Python, C. P., Inoue, S. B., Arisawa, M., Anraku, Y., Zheng, Y., Watanabe, T., Levin, D. E., and Ohya, Y. (1996) Science 272, 279–281[Abstract]
  33. Kamada, Y., Qadota, H., Pyton, C. P., Anraku, Y., Ohya, Y., and Levin, D. E. (1996) J. Biol. Chem. 271, 9193–9196[Abstract/Free Full Text]
  34. Levin, D. E., Fields, F. O., Kunisawa, R., Bishop, J. M., and Thorner, J. (1990) Cell 62, 213–224[Medline] [Order article via Infotrieve]
  35. Stevenson, B. J., Rhodes, N., Errede, B., and Sprague, G. F. (1992) Genes Dev. 6, 1293–1304[Abstract]
  36. Masuda, T., Tanaka, K., Nonaka, H., Yamochi, W., Maeda, A., and Takai, Y. (1994) J. Biol. Chem. 269, 19713–19718[Abstract/Free Full Text]
  37. Kim, J., Bortz, E., Zhong, H., Leeuw, T., Leberer, E., Vershon, A. K., and Hirsch, J. P. (2000) Mol. Cell. Biol. 20, 8826–8835[Abstract/Free Full Text]
  38. Ayscough, K. R., and Drubin, D. G. (1998) Curr. Biol. 8, 927–930[Medline] [Order article via Infotrieve]
  39. Yamochi, W., Tanaka, K., Nonaka, H., Maeda, A., Musha, T., and Takai, Y. (1994) J. Cell Biol. 125, 1077–1093[Abstract]
  40. Nonaka, H., Tanaka, K., Hirano, H., Fujiwara, T., Kohno, H., Umikawa, M., Mino, A., and Takai, Y. (1995) EMBO J. 14, 5931–5938[Abstract]
  41. Kraynov, V. S., Chamberlain, C., Bokoch, G. M., Schwartz, M. A., Slabaugh, S., and Hahn, K. M. (2000) Science 290, 333–337[Abstract/Free Full Text]
  42. Sekiya-Kawasaki, M., Abe, M., Saka, A., Watanabe, D., Kono, K., Minemura-Asakawa, M., Ishihara, S., Watanabe, T., and Ohya, Y. (2002) Genetics 162, 663–676[Abstract/Free Full Text]
  43. Saka, A., Abe, M., Okano, H., Minemura, M., Qadota, H., Utsugi, T., Mino, A., Tanaka, K., Takai, Y., and Ohya, Y. (2001) J. Biol. Chem. 276, 46165–46171[Abstract/Free Full Text]
  44. Tanaka, E., and Sabry, J. (1995) Cell 83, 171–176[Medline] [Order article via Infotrieve]
  45. Haugh, J., Jason, M., Codazzi, F., Teruel, M., and Meyer, T. (2000) J. Cell Biol. 151, 1269–1279[Abstract/Free Full Text]
  46. Duchek, P., and Rorth, P. (2001) Science 291, 131–133[Abstract/Free Full Text]
  47. Harhammer, R., Gohla, A., and Shultz, G. (1996) FEBS Lett. 399, 211–214[CrossRef][Medline] [Order article via Infotrieve]
  48. Alberts, A. S., Bouquin, N., Johnston, L. H., and Triesman, R. (1998) J. Biol. Chem. 273, 8616–8622[Abstract/Free Full Text]
  49. Thodeti, C. K., Massoumi, R., Bindslev, L., and Sjolander, A. (2002) Biochem. J. 365, 157–163[CrossRef][Medline] [Order article via Infotrieve]
  50. Buehrer, B. M., and Errede, B. (1997) Mol. Cell. Biol. 17, 6517–6525[Abstract]
  51. Andrews, P. D., and Stark, M. J. (2000) J. Cell Sci. 113, 2685–2693[Abstract/Free Full Text]